Abatacept
The risk or severity of adverse effects can be increased when Abatacept is combined with Rotavirus Vaccine.
Abciximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Abciximab.
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Rotavirus Vaccine.
Advertisement
Adalimumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Adalimumab.
Adefovir
The risk or severity of adverse effects can be increased when Adefovir is combined with Rotavirus Vaccine.
Ado-Trastuzumab Emtansine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Rotavirus Vaccine.
Advertisement
Alclometasone
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rotavirus Vaccine.
Aldosterone
The risk or severity of adverse effects can be increased when Aldosterone is combined with Rotavirus Vaccine.
Alefacept
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Alefacept.
Advertisement
Alemtuzumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Alemtuzumab.
Alirocumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Alirocumab.
Altretamine
The risk or severity of adverse effects can be increased when Altretamine is combined with Rotavirus Vaccine.
Amcinonide
The risk or severity of adverse effects can be increased when Amcinonide is combined with Rotavirus Vaccine.
Amsacrine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Amsacrine.
Anakinra
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Anakinra.
Androstenedione
The risk or severity of adverse effects can be increased when Androstenedione is combined with Rotavirus Vaccine.
Anhydrous Tacrolimus
The risk or severity of adverse effects can be increased when Tacrolimus is combined with Rotavirus Vaccine.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Rotavirus Vaccine.
Asfotase Alfa
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Asfotase Alfa.
Atezolizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Atezolizumab.
Avelumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Avelumab.
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Rotavirus Vaccine.
Azathioprine
The risk or severity of adverse effects can be increased when Azathioprine is combined with Rotavirus Vaccine.
Basiliximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Basiliximab.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Rotavirus Vaccine.
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Rotavirus Vaccine.
Belimumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Belimumab.
Benznidazole
The risk or severity of adverse effects can be increased when Benznidazole is combined with Rotavirus Vaccine.
Betamethasone
The risk or severity of adverse effects can be increased when Betamethasone is combined with Rotavirus Vaccine.
Bevacizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Bevacizumab.
Bevacizumab-Awwb
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Bevacizumab.
Bleomycin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Bleomycin.
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Rotavirus Vaccine.
Brentuximab Vedotin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rotavirus Vaccine.
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Rotavirus Vaccine.
Budesonide
The risk or severity of adverse effects can be increased when Budesonide is combined with Rotavirus Vaccine.
Busulfan
The risk or severity of adverse effects can be increased when Busulfan is combined with Rotavirus Vaccine.
C1 esterase inhibitor (human)
The risk or severity of adverse effects can be increased when Human C1-esterase inhibitor is combined with Rotavirus Vaccine.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Rotavirus Vaccine.
Canakinumab
The risk or severity of adverse effects can be increased when Canakinumab is combined with Rotavirus Vaccine.
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Rotavirus Vaccine.
Capromab Pendetide
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Capromab pendetide.
Carboplatin
The risk or severity of adverse effects can be increased when Carboplatin is combined with Rotavirus Vaccine.
Carmustine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Carmustine.
Certolizumab Pegol
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Rotavirus Vaccine.
Cetuximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Cetuximab.
Chlorambucil
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Chlorambucil.
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Rotavirus Vaccine.
Cisplatin
The risk or severity of adverse effects can be increased when Cisplatin is combined with Rotavirus Vaccine.
Cladribine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Cladribine.
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Rotavirus Vaccine.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Rotavirus Vaccine.
Clobetasone
The risk or severity of adverse effects can be increased when Clobetasone is combined with Rotavirus Vaccine.
Clocortolone
The risk or severity of adverse effects can be increased when Clocortolone is combined with Rotavirus Vaccine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Rotavirus Vaccine.
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Rotavirus Vaccine.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Rotavirus Vaccine.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Rotavirus Vaccine.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Rotavirus Vaccine.
Cyclosporine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Cyclosporine.
Cytarabine
The risk or severity of adverse effects can be increased when Cytarabine is combined with Rotavirus Vaccine.
Cytomegalovirus Immune Globulin, Human
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Cytomegalovirus immunoglobulin.
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Rotavirus Vaccine.
Daclizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Daclizumab.
Dactinomycin
The risk or severity of adverse effects can be increased when Dactinomycin is combined with Rotavirus Vaccine.
Dalotuzumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Dalotuzumab.
Daratumumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Daratumumab.
Dasatinib
The risk or severity of adverse effects can be increased when Dasatinib is combined with Rotavirus Vaccine.
Dasatinib Anhydrous
The risk or severity of adverse effects can be increased when Dasatinib is combined with Rotavirus Vaccine.
Daunorubicin
The risk or severity of adverse effects can be increased when Daunorubicin is combined with Rotavirus Vaccine.
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Rotavirus Vaccine.
Denosumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Denosumab.
Desonide
The risk or severity of adverse effects can be increased when Desonide is combined with Rotavirus Vaccine.
Desoximetasone
The risk or severity of adverse effects can be increased when Desoximetasone is combined with Rotavirus Vaccine.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Desoxycorticosterone acetate is combined with Rotavirus Vaccine.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Desoxycorticosterone Pivalate is combined with Rotavirus Vaccine.
Dexamethasone
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Rotavirus Vaccine.
Diflorasone
The risk or severity of adverse effects can be increased when Diflorasone is combined with Rotavirus Vaccine.
Diflucortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Rotavirus Vaccine.
Difluprednate
The risk or severity of adverse effects can be increased when Difluprednate is combined with Rotavirus Vaccine.
Dimethyl Fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Rotavirus Vaccine.
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Rotavirus Vaccine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Rotavirus Vaccine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Rotavirus Vaccine.
Doxorubicin
The risk or severity of adverse effects can be increased when Doxorubicin is combined with Rotavirus Vaccine.
Doxorubicin Hydrochloride
The risk or severity of adverse effects can be increased when Doxorubicin is combined with Rotavirus Vaccine.
Dulaglutide
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Dulaglutide.
Dupilumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Dupilumab.
Durvalumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Durvalumab.
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Rotavirus Vaccine.
Edrecolomab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Edrecolomab.
Efalizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Efalizumab.
Elotuzumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Elotuzumab.
Emicizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Emicizumab.
Emicizumab-Kxwh
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Emicizumab.
Epirubicin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Epirubicin.
Estramustine
The risk or severity of adverse effects can be increased when Estramustine is combined with Rotavirus Vaccine.
Estrone
The risk or severity of adverse effects can be increased when Estrone is combined with Rotavirus Vaccine.
Etanercept
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Etanercept.
Etoposide
The risk or severity of adverse effects can be increased when Etoposide is combined with Rotavirus Vaccine.
Everolimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Rotavirus Vaccine.
Evolocumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Evolocumab.
Fingolimod
The risk or severity of adverse effects can be increased when Fingolimod is combined with Rotavirus Vaccine.
Floxuridine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Floxuridine.
Fludarabine
The risk or severity of adverse effects can be increased when Fludarabine is combined with Rotavirus Vaccine.
Fludrocortisone
The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Rotavirus Vaccine.
Flumethasone
The risk or severity of adverse effects can be increased when Flumethasone is combined with Rotavirus Vaccine.
Flunisolide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rotavirus Vaccine.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rotavirus Vaccine.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rotavirus Vaccine.
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Rotavirus Vaccine.
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Rotavirus Vaccine.
Fluorometholone
The risk or severity of adverse effects can be increased when Fluorometholone is combined with Rotavirus Vaccine.
Fluorouracil
The risk or severity of adverse effects can be increased when Fluorouracil is combined with Rotavirus Vaccine.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Rotavirus Vaccine.
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Rotavirus Vaccine.
Flurandrenolide
The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Rotavirus Vaccine.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Rotavirus Vaccine.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Rotavirus Vaccine.
Formestane
The risk or severity of adverse effects can be increased when Formestane is combined with Rotavirus Vaccine.
Gallium Nitrate
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Rotavirus Vaccine.
Gemcitabine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Gemcitabine.
Gemtuzumab ozogamicin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Gemtuzumab ozogamicin.
Glatiramer Acetate
The risk or severity of adverse effects can be increased when Glatiramer Acetate is combined with Rotavirus Vaccine.
Glimepiride
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Glimepiride.
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Rotavirus Vaccine.
Guselkumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Guselkumab.
Halcinonide
The risk or severity of adverse effects can be increased when Halcinonide is combined with Rotavirus Vaccine.
Halobetasol
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Rotavirus Vaccine.
Hydrocortisone
The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Rotavirus Vaccine.
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Rotavirus Vaccine.
Hypericin
The risk or severity of adverse effects can be increased when Hypericin is combined with Rotavirus Vaccine.
Ibalizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ibalizumab.
Ibalizumab-Uiyk
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ibalizumab.
Ibritumomab Tiuxetan
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Rotavirus Vaccine.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Rotavirus Vaccine.
Idarubicin
The risk or severity of adverse effects can be increased when Idarubicin is combined with Rotavirus Vaccine.
Idarucizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Idarucizumab.
Idelalisib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Rotavirus Vaccine.
Ifosfamide
The risk or severity of adverse effects can be increased when Ifosfamide is combined with Rotavirus Vaccine.
Imatinib
The risk or severity of adverse effects can be increased when Imatinib is combined with Rotavirus Vaccine.
Imiquimod
The risk or severity of adverse effects can be increased when Imiquimod is combined with Rotavirus Vaccine.
Immunoglobulin G, Human
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Immune Globulin Human.
Immunoglobulins, Intravenous
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Immune Globulin Human.
Infliximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Infliximab.
Infliximab-Abda
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Infliximab.
Infliximab-Dyyb
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Infliximab.
Inotuzumab Ozogamicin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Ipilimumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ipilimumab.
Irinotecan
The risk or severity of adverse effects can be increased when Irinotecan is combined with Rotavirus Vaccine.
Ixekizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ixekizumab.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Rotavirus Vaccine.
Lenalidomide
The risk or severity of adverse effects can be increased when Lenalidomide is combined with Rotavirus Vaccine.
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Rotavirus Vaccine.
Loteprednol
The risk or severity of adverse effects can be increased when Loteprednol is combined with Rotavirus Vaccine.
Mechlorethamine
The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Rotavirus Vaccine.
Medrysone
The risk or severity of adverse effects can be increased when Medrysone is combined with Rotavirus Vaccine.
Melphalan
The risk or severity of adverse effects can be increased when Melphalan is combined with Rotavirus Vaccine.
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Rotavirus Vaccine.
Mercaptopurine
The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Rotavirus Vaccine.
MERCAPTOPURINE ANHYDROUS
The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Rotavirus Vaccine.
Methotrexate
The risk or severity of adverse effects can be increased when Methotrexate is combined with Rotavirus Vaccine.
Methylprednisolone
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Rotavirus Vaccine.
Mitomycin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Mitomycin.
Mitoxantrone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Rotavirus Vaccine.
Mometasone
The risk or severity of adverse effects can be increased when Mometasone is combined with Rotavirus Vaccine.
Muromonab-CD3
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Muromonab.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Rotavirus Vaccine.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Rotavirus Vaccine.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Rotavirus Vaccine.
Natalizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Natalizumab.
Necitumumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Necitumumab.
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Rotavirus Vaccine.
Nilotinib
The risk or severity of adverse effects can be increased when Nilotinib is combined with Rotavirus Vaccine.
Nivolumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Nivolumab.
Obiltoxaximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Obiltoxaximab.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Rotavirus Vaccine.
Ocrelizumab
The therapeutic efficacy of Ocrelizumab can be decreased when used in combination with Rotavirus Vaccine.
Ofatumumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ofatumumab.
Olaratumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Olaratumab.
Omalizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Omalizumab.
Oxaliplatin
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Rotavirus Vaccine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Rotavirus Vaccine.
Palbociclib
The risk or severity of adverse effects can be increased when Palbociclib is combined with Rotavirus Vaccine.
Palivizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Palivizumab.
Panitumumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Panitumumab.
Panobinostat
The risk or severity of adverse effects can be increased when Panobinostat is combined with Rotavirus Vaccine.
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Rotavirus Vaccine.
Pazopanib
The risk or severity of adverse effects can be increased when Pazopanib is combined with Rotavirus Vaccine.
Pegaspargase
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Pegaspargase.
Pembrolizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Pembrolizumab.
Pemetrexed
The risk or severity of adverse effects can be increased when Pemetrexed is combined with Rotavirus Vaccine.
Pentostatin
The risk or severity of adverse effects can be increased when Pentostatin is combined with Rotavirus Vaccine.
Pertuzumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Pertuzumab.
Phenylalanine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with L-Phenylalanine.
Pimecrolimus
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Pimecrolimus.
Pirarubicin
The risk or severity of adverse effects can be increased when Pirarubicin is combined with Rotavirus Vaccine.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Rotavirus Vaccine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Rotavirus Vaccine.
Pralatrexate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Rotavirus Vaccine.
Prasterone
The risk or severity of adverse effects can be increased when Prasterone is combined with Rotavirus Vaccine.
Prednicarbate
The risk or severity of adverse effects can be increased when Prednicarbate is combined with Rotavirus Vaccine.
Prednisolone
The risk or severity of adverse effects can be increased when Prednisolone is combined with Rotavirus Vaccine.
Prednisone
The risk or severity of adverse effects can be increased when Prednisone is combined with Rotavirus Vaccine.
Pregnenolone
The risk or severity of adverse effects can be increased when Pregnenolone is combined with Rotavirus Vaccine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Rotavirus Vaccine.
Rabbit anti-human T-lymphocyte globulin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Ramucirumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ramucirumab.
Ranibizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Ranibizumab.
Raxibacumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Raxibacumab.
Reslizumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Reslizumab.
Rilonacept
The risk or severity of adverse effects can be increased when Rilonacept is combined with Rotavirus Vaccine.
Rimexolone
The risk or severity of adverse effects can be increased when Rimexolone is combined with Rotavirus Vaccine.
Rituximab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Rituximab.
Ruxolitinib
The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Rotavirus Vaccine.
Sarilumab
The risk or severity of infection can be increased when Sarilumab is combined with Rotavirus Vaccine.
Secukinumab
The risk or severity of adverse effects can be increased when Secukinumab is combined with Rotavirus Vaccine.
Siltuximab
The risk or severity of adverse effects can be increased when Siltuximab is combined with Rotavirus Vaccine.
Sirolimus
The risk or severity of adverse effects can be increased when Sirolimus is combined with Rotavirus Vaccine.
Sorafenib
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Sorafenib.
Streptozocin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Streptozocin.
Sunitinib
The risk or severity of adverse effects can be increased when Sunitinib is combined with Rotavirus Vaccine.
Tacrolimus
The risk or severity of adverse effects can be increased when Tacrolimus is combined with Rotavirus Vaccine.
technetium Tc 99m arcitumomab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Technetium Tc-99m arcitumomab.
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Rotavirus Vaccine.
Temsirolimus
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Rotavirus Vaccine.
Teniposide
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Teniposide.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Rotavirus Vaccine.
Tetanus immune globulin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Tetanus Immune Globulin.
Tetanus immune globulin, human
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Tetanus Immune Globulin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Rotavirus Vaccine.
Thioguanine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Tioguanine.
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Rotavirus Vaccine.
Thymocyte Immunoglobulin, Equine
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Rotavirus Vaccine.
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Rotavirus Vaccine.
Tocilizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Rotavirus Vaccine.
Tofacitinib
The risk or severity of adverse effects can be increased when Tofacitinib is combined with Rotavirus Vaccine.
Topotecan
The risk or severity of adverse effects can be increased when Topotecan is combined with Rotavirus Vaccine.
Tositumomab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Tositumomab.
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Rotavirus Vaccine.
Trastuzumab
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Trastuzumab.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Rotavirus Vaccine.
Triamcinolone
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rotavirus Vaccine.
Trofosfamide
The risk or severity of adverse effects can be increased when Trofosfamide is combined with Rotavirus Vaccine.
Ustekinumab
The risk or severity of adverse effects can be increased when Ustekinumab is combined with Rotavirus Vaccine.
Varicella zoster immune globulin (human)
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Human Varicella-Zoster Immune Globulin.
Varicella-Zoster Immune Globulin
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Human Varicella-Zoster Immune Globulin.
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Rotavirus Vaccine.
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Rotavirus Vaccine.
Vinblastine
The risk or severity of adverse effects can be increased when Vinblastine is combined with Rotavirus Vaccine.
Vincristine
The risk or severity of adverse effects can be increased when Vincristine is combined with Rotavirus Vaccine.
Vindesine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Vindesine.
Vinorelbine
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Vinorelbine.
